Trial intelligence / Profile preview

Articaine vs Lidocaine for Pulpectomy in Children

NCT05944341Unknown

Sponsor
Minia University
Start
Jun 2023
Primary completion
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of articaine in irreversible pulpitis (2 arms), sponsored by Minia University. Primary endpoint: Face, Legs, Activity, Cry, Consolability pain scale up to 24 hours. Status: unknown.

02

Drugs

articaine
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on NCT05944341.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05944341.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call